Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)

Molecular Medicine

Volumn 14, Issue 9-10, 2008, Pages 618-627

  McCarthy, Brian A ^a   Boyle, Erin ^a   Xue, Ping Wang ^a   Guzowski, Dorothy ^a   Paul, Santanu ^a   Catera, Rosa ^a   Trott, Joshua ^a   Yan, Xiao Jie ^a   Croce, Carlo M ^b   Damle, Rajendra ^a   Yancopoulos, Sophia ^a   Messmer, Bradley T ^c   Lesser, Martin ^d   Allen, Steven L ^a,d   Rai, Kanti R ^a,e   Chiorazzi, Nicholas ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^e LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; CELL MEMBRANE; CELL SURFACE; CHROMOSOME BREAKAGE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURFACE PROPERTY; UPREGULATION;

APOPTOSIS; B-LYMPHOCYTES; CELL MEMBRANE; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 55049138286     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008.00061.McCarthy     Document Type: Article

References (39)

1. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-3.
2. Reed JC. (2008) Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 111:3322-30.
3. Chao DT, Korsmeyer SJ. (1998) BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:395-419.
4. Danial NN, Korsmeyer SJ. (2004) Cell death: critical control points. Cell 116:205-19.
5. Danial NN. (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin. Cancer Res. 13:7254-63.
6. Ciardiello F, Tortora G. (2002) Inhibition of bcl-2 as cancer therapy. Ann. Oncol. 13:501-2.
7. Del Gaizo Moore V, et al. (2007) Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J. Clin. Invest. 117:112-21.
8. Shirane M, Nakayama KI. (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell. Biol. 5:28-37.
9. Fischer G, Aumuller T. (2003) Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 148:105-50.
10. Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC. (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268:25265-8.
11. Yang J, et al. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-32.
12. Green DR, Reed JC. (1998) Mitochondria and apoptosis. Science 281:1309-12.
13. Krajewski S, et al. (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701-14.
14. Portier BP, Taglialatela G. (2006) Bcl-2 localized at the nuclear compartment induces apoptosis after transient overexpression. J. Biol. Chem. 281:40493-502.
15. Stacchini A, et al. (1999) MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk. Res. 23:127-36.
16. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271-9.
17. McCloskey TW, Oyaizu N, Coronesi M, Pahwa S. (1994) Use of a flow cytometric assay to quantitate apoptosis in human lymphocytes. Clin. Immunol. Immunopathol. 71:14-8.
18. Gottardi D, et al. (1996) In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. Br. J. Haematol. 94:612-8.
19. Bhat NM, et al. (1992) The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int. Immunol. 4:243-52.
20. Kipps TJ. (1989) The CD5 B cell. Adv. Immunol. 47:117-85.
21. Sapozhnikov AM, Gusarova GA, Ponomarev ED, Telford WG. (2002) Translocation of cytoplasmic HSP70 onto the surface of EL-4 cells during apoptosis. Cell. Prolif. 35:193-206.
22. Silber R, et al. (1994) Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood 84:3440-6.
23. Mei Y, et al. (2007) Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia 9:871-81.
24. Chen-Levy Z, Nourse J, Cleary ML. (1989) The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell. Biol. 9:701-10.
25. Bruce-Keller AJ, et al. (1998) Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J. Neurochem. 70:31-9.
26. Steller H. (1995) Mechanisms and genes of cellular suicide. Science 267:1445-9.
27. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-51.
28. Nguyen M, et al. (1994) Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem. 269:16521-4.
29. Falini B, et al. (2004) Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363:1869-70.
30. Ellis RE, Yuan JY, Horvitz HR. (1991) Mechanisms and functions of cell death. Annu. Rev. Cell. Biol. 7:663-98.
31. Hacker G, Vaux DL. (1997) A chronology of cell death. Apoptosis 2:247-56.
32. Takashina T, Nakayama M. (2007) Revival of apoptotic cells that display early-stage dynamic membrane blebbing. FEBS Lett. 581:4479-84.
33. Torgerson RR, McNiven MA. (1998) The actinmyosin cytoskeleton mediates reversible agonistinduced membrane blebbing. J. Cell. Sci. 111 (Pt 19):2911-22.
34. Raval A, et al. (2007) Downregulation of deathassociated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129:879.
35. Schroder M, Kaufman RJ. (2005) The mammalian unfolded protein response. Annu. Rev. Biochem. 74:739-789.
36. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol. 8:741-52.
37. Zinkel S, Gross A, Yang E. (2006) BCL2 family in DNA damage and cell cycle control. Cell. Death Differ. 13:1351-9.
38. Kamer I, et al. (2005) Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122:593-603.
39. Danial NN, et al. (2003) BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424:952-6.